Fredrik Lehmann
Directeur/Bestuurslid bij GUARD THERAPEUTICS INTERNATIONAL AB
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Tobias Larsson Agervald | M | 48 | 6 jaar | |
Martin Andersson | M | 53 | 15 jaar | |
Sofia Heigis | F | 44 | 4 jaar | |
Jonas Jendi | M | 54 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 7 jaar |
Sara Mangsbo | M | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 jaar |
Nils Rune Nordlander | M | 68 | 14 jaar | |
Per Wold-Olsen | M | 76 | 6 jaar | |
Johan Bygge | M | 68 | 3 jaar | |
Jennifer Jackson | M | 71 | 6 jaar | |
Eva Nordström | F | 54 | 12 jaar | |
Brian Stuglik | M | 64 | 6 jaar | |
Thomas Totterman | M | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 jaar |
Johannes Hulthe | M | 54 | 5 jaar | |
Mathias Skalmstad | M | 51 | 13 jaar | |
Lars Lund | M | - |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
Iliam Barkino | M | - |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 3 jaar |
Karin From | F | 54 | 1 jaar | |
Jarl Ulf Birger Jungnelius | M | 73 | 13 jaar | |
Erika Fletcher | F | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 jaar |
Lars Höckenström | M | 68 | 5 jaar | |
Anette Asklin | F | 63 |
University of Gothenburg
| 17 jaar |
Göran Forsberg | M | 61 | 5 jaar | |
Stig Anders Lindberg | M | 52 | 13 jaar | |
Per Anders Göte Samuelsson | M | 63 | 12 jaar | |
Cecilia Margaretha Daun-Wennborg | F | 61 | 7 jaar | |
Anna Haupt | F | - |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 3 jaar |
Charlotta Poehler | F | - |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
Ester Sklarsky | F | - |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 5 jaar |
Karin Hehenberger | M | 52 |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
Patrik Strömberg | M | - |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | 3 jaar |
Björn Magnus Sjöstrand | M | 56 | 3 jaar | |
Michael Reusch | M | 64 | 2 jaar | |
Karolina Bjurehed | F | 46 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 2 jaar |
Torbjörn Larsson | M | - | 2 jaar | |
Karl Elmqvist | M | - |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | 2 jaar |
Caroline Wachtmeister | F | - |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 2 jaar |
Svein Arild Mathisen | M | 68 | 4 jaar | |
Mala Valroy | M | - |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 2 jaar |
Jörgen Lönngren | M | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | - |
Sara Svardgren | F | 45 | 6 jaar | |
Sara Thuresson | F | 48 | 3 jaar | |
Justyna Leja-Jarblad | M | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | - |
Johan Dighed | M | 51 |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
Christian Salamon | M | 63 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | - |
Magnus Sjögren | M | 60 |
University of Gothenburg
| 22 jaar |
Per Johan Anell | M | 56 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 10 jaar |
Rolf Tore Tolke | M | 53 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 17 jaar |
Thomas Görling | M | 76 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 26 jaar |
Matti Zemack | M | 51 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 3 jaar |
Lars Olov Jonsson | M | 72 |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 jaar |
Anna Ljungdahl | F | - |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 5 jaar |
Jonas Karl Olaf Brambeck | M | 66 |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 26 jaar |
Anne-Marie Wenthzel | F | - | 13 jaar | |
Camilla Huse Bondesson | M | 66 |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | 10 jaar |
Patrik Sobocki | M | - |
Industrifonden
Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | 8 jaar |
John Öhd | M | 53 |
AnaCardio AB
AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | - |
Karin Botha | F | 51 | 4 jaar | |
Charlotte Leife | F | - |
Immuneed AB
Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | - |
Johan Emilsson | M | 40 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Johnny Bäverås | M | - |
University of Gothenburg
| 4 jaar |
Jan-Erik Nyström | M | 71 | - | |
Fredrik Biesèrt | M | - |
Stockholm School of Economics
| 5 jaar |
Pia Magnhild Helena Gideon | F | 70 | 2 jaar | |
Anders Åberg | M | 66 | 10 jaar | |
Jonas Skilje | M | - |
Stockholm School of Economics
| 5 jaar |
Olof Tydén | M | 77 | - | |
Rolf Gulliksen | M | 65 | 3 jaar | |
Erik Kinnman | M | 66 | 2 jaar | |
Luigi Costa | M | 59 | - | |
Alan Hulme | M | - | 8 jaar | |
Karin Eklund Vanderpol | F | 51 | 2 jaar | |
Karolina Vilval | F | 45 | 2 jaar | |
Maria Kristina McDonald | F | 43 |
University of Gothenburg
| 3 jaar |
Izabella Källholm | F | - |
Stockholm School of Economics
| 2 jaar |
Martin Duvall | M | 62 | 1 jaar | |
Carlos Emilio Gómez | M | - |
University of Gothenburg
| - |
Han Jing Xie | M | 54 | 2 jaar | |
Jakob Brevinge | M | 41 |
University of Gothenburg
| 3 jaar |
Mateo Steinbach-Künkler | M | - |
Stockholm School of Economics
| 2 jaar |
Maximilian Stärk | M | - |
Stockholm School of Economics
| 2 jaar |
Douglas Persson | M | - |
Stockholm School of Economics
| 2 jaar |
Jesper Backas | M | - |
University of Gothenburg
| 5 jaar |
Zaki Ghazal | M | - |
Stockholm School of Economics
| 2 jaar |
Christian Jacques | M | 68 | 2 jaar | |
Klaas Bakker | M | 42 | - | |
Dominik Faruk Esen | M | - |
Stockholm School of Economics
| 2 jaar |
Jonas Fjellman | M | 45 |
University of Gothenburg
| 1 jaar |
Johan Georg Harmenberg | M | 70 | 7 jaar | |
Johanna Gräns | M | - |
University of Gothenburg
| 3 jaar |
Gunnar Steineck | M | - |
University of Gothenburg
| - |
Pam Fredman | M | 74 |
University of Gothenburg
| - |
Victor Fredrik Bodin | M | - |
University of Gothenburg
| 3 jaar |
Elisabeth Augustsson | F | 59 | 5 jaar | |
Jaime Blas Boville | M | - |
University of Gothenburg
| 1 jaar |
Anders Martin-Löf | M | 53 | 3 jaar | |
Karin Birgitta Margareta Ståhl | F | 53 | 2 jaar | |
Lena G. E. Mårtensson Lindbald | M | - |
University of Gothenburg
| - |
Rein Piir | M | 66 | 4 jaar | |
Jon Hyltner | M | - |
University of Gothenburg
| 1 jaar |
Lena Roseke | F | - |
University of Gothenburg
| 3 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Zweden | 100 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Fredrik Lehmann
- Persoonlijk netwerk